Paula’s Choice CLINICAL 1% Retinol Treatment Cream with Peptides, Vitamin C & Licorice Extract, Anti-Aging & Wrinkles, Travel Size. PACKAGING MAY VARY.
$15.00
Price: $15.00
(as of Apr 23, 2024 06:46:02 UTC – Details)
From the brand
Shop Our Best Sellers
Is Discontinued By Manufacturer : No
Package Dimensions : 3.7 x 3.16 x 0.87 inches; 0.63 ounces
UPC : 655439080170
Manufacturer : Paula’s Choice
ASIN : B00L5O31VK
Country of Origin : USA
DIMINISH THE APPEARANCE OF WRINKLES: This expert-level, high-strength formula absorbs quickly & delivers immediate powerful results. Antioxidant vitamins C &E paired with hydrating hyaluronic acid and skin-firming peptides help deliver advanced anti-aging results. PACKAGING MAY VARY.
Paula’s Choice CLINICAL 1% Retinol Treatment with Peptides & Vitamin C is formulated to reduce the appearance of wrinkles as it refines pores and firms skin for a radiant, rejuvenated, more youthful appearance. This robust formula also helps prevent signs of aging and softens the look of post-acne marks.
Paula’s Choice CLINICAL 1% Retinol is an ideal anti-aging serum for normal, combination, dry, & oily skin. Try mixing with 2-3 drops of Paula’s Choice Moisture Renewal Oil Booster. Use at night with Paula’s Choice cleanser, toner, exfoliator & night cream.
Paula’s Choice products are made with YOUR SKIN in mind. Whatever your skincare concern, whether dryness, acne, fine lines, or sensitive skin; we’ve got a treatment line for you. The search for amazing skin care ends here. Finally, you found it.
SUSTAINABLE PACKAGING: As part of our pledge to the planet, we’re removing extra plastic from packaging, like shrink wrap.
Paula’s Choice Skincare makes products that work. No fragrance, no parabens, no fluff. Just effective, science-backed formulas that target any concern from wrinkles to breakouts.
User Reviews
Be the first to review “Paula’s Choice CLINICAL 1% Retinol Treatment Cream with Peptides, Vitamin C & Licorice Extract, Anti-Aging & Wrinkles, Travel Size. PACKAGING MAY VARY.”
$15.00
There are no reviews yet.